Dylan J. Martini

3.2k total citations
68 papers, 1.0k citations indexed

About

Dylan J. Martini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Dylan J. Martini has authored 68 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Dylan J. Martini's work include Renal cell carcinoma treatment (31 papers), Cancer Immunotherapy and Biomarkers (30 papers) and Bladder and Urothelial Cancer Treatments (19 papers). Dylan J. Martini is often cited by papers focused on Renal cell carcinoma treatment (31 papers), Cancer Immunotherapy and Biomarkers (30 papers) and Bladder and Urothelial Cancer Treatments (19 papers). Dylan J. Martini collaborates with scholars based in United States, Canada and Italy. Dylan J. Martini's co-authors include Toni K. Choueiri, Lauren C. Harshman, Mehmet Asım Bilen, John A. Steinharter, Bradley A. McGregor, Aly‐Khan A. Lalani, Wanling Xie, Dominick Bossé, Viraj A. Master and Bradley Curtis Carthon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dylan J. Martini

63 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dylan J. Martini United States	17	729	422	186	166	152	68	1.0k
Florian Kocher Austria	18	498 0.7×	357 0.8×	130 0.7×	215 1.3×	89 0.6×	72	990
J. Feng China	15	660 0.9×	425 1.0×	221 1.2×	291 1.8×	88 0.6×	71	1.0k
Abdul Rafeh Naqash United States	18	1.3k 1.7×	479 1.1×	94 0.5×	224 1.3×	278 1.8×	103	1.5k
Lara Pijuán Spain	20	571 0.8×	680 1.6×	168 0.9×	307 1.8×	105 0.7×	74	1.3k
Su Jin Heo South Korea	16	553 0.8×	333 0.8×	220 1.2×	188 1.1×	130 0.9×	38	904
Sandra J. Casak United States	18	455 0.6×	215 0.5×	189 1.0×	171 1.0×	138 0.9×	32	1.0k
Darrin Despain United States	14	322 0.4×	704 1.7×	157 0.8×	172 1.0×	270 1.8×	28	1.5k
Terenig Terjanian United States	10	490 0.7×	182 0.4×	163 0.9×	126 0.8×	122 0.8×	30	935
Mona Fouad Egypt	16	638 0.9×	278 0.7×	95 0.5×	157 0.9×	93 0.6×	32	896

Countries citing papers authored by Dylan J. Martini

Since Specialization

Citations

This map shows the geographic impact of Dylan J. Martini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dylan J. Martini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dylan J. Martini more than expected).

Fields of papers citing papers by Dylan J. Martini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dylan J. Martini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dylan J. Martini. The network helps show where Dylan J. Martini may publish in the future.

Co-authorship network of co-authors of Dylan J. Martini

This figure shows the co-authorship network connecting the top 25 collaborators of Dylan J. Martini. A scholar is included among the top collaborators of Dylan J. Martini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dylan J. Martini. Dylan J. Martini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yuan, Dylan J. Martini, Wayne Harris, et al.. (2025). Non-clear cell renal cell carcinoma in the immune checkpoint era: A retrospective study on survival and treatment approaches.. Journal of Clinical Oncology. 43(5_suppl). 512–512. 1 indexed citations

Martini, Dylan J., Samuel Bidot, Bassel Nazha, et al.. (2024). Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes. American Journal of Clinical Pathology. 163(4). 618–628. 2 indexed citations

Martini, Dylan J., Kathryn L. Pellegrini, Elizabeth Beagle, et al.. (2024). PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation. Cancer. 130(21). 3658–3670. 4 indexed citations

Short, Samuel, Charlotte Thomas, Dylan J. Martini, et al.. (2023). AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation. 59(2). 178–188. 3 indexed citations

Nguyen, Thinh H., Deepak Kumar, Chengyu Prince, et al.. (2023). Frequency of HLA-DR+CD38hi T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders. Journal of Allergy and Clinical Immunology. 153(1). 309–319. 24 indexed citations

Sanda, Gregory E., Julie M. Shabto, Subir Goyal, et al.. (2023). Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors. The Oncologist. 28(12). 1072–1078. 7 indexed citations

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2022). Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. SHILAP Revista de lepidopterología. 5(3). 52–57. 1 indexed citations

Patil, Dattatraya, Dylan J. Martini, Sarah P. Psutka, et al.. (2022). Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma. Urologic Oncology Seminars and Original Investigations. 41(1). 50.e19–50.e26. 9 indexed citations

Bidot, Samuel, Dylan J. Martini, Mehmet Asım Bilen, et al.. (2022). Risk Stratification of Prostatic Adenocarcinoma Metastatic to the Lymph Nodes. Archives of Pathology & Laboratory Medicine. 146(11). 1345–1352. 1 indexed citations

10.

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in Oncology. 11. 701345–701345. 7 indexed citations

11.

Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in Oncology. 11. 707050–707050. 26 indexed citations

12.

Martini, Dylan J., Yuan Liu, Julie M. Shabto, et al.. (2021). Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib. Cancer Treatment and Research Communications. 28. 100393–100393. 4 indexed citations

13.

Martini, Dylan J., Yuan Liu, Julie M. Shabto, et al.. (2021). Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients. Clinical Genitourinary Cancer. 20(1). 53–59. 7 indexed citations

14.

Ravindranathan, Deepak, Yuan Liu, Dylan J. Martini, et al.. (2021). Clinical outcomes in metastatic renal cell carcinoma (mRCC) treated with combination of nivolumab and cabozantinib (nivo-cabo) in the salvage setting.. Journal of Clinical Oncology. 39(15_suppl). e16570–e16570. 1 indexed citations

15.

Shabto, Julie M., Dylan J. Martini, Yuan Liu, et al.. (2020). Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer Medicine. 9(8). 2752–2760. 8 indexed citations

16.

McGregor, Bradley A., Aly‐Khan A. Lalani, Wanling Xie, et al.. (2020). Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma. European Journal of Cancer. 135. 203–210. 53 indexed citations

17.

Martini, Dylan J., Dattatraya Patil, Sarah P. Psutka, et al.. (2020). Quantification of body composition in renal cell carcinoma patients: Comparing computed tomography and magnetic resonance imaging measurements. European Journal of Radiology. 132. 109307–109307. 12 indexed citations

18.

Bilen, Mehmet Asım, Julie M. Shabto, Dylan J. Martini, et al.. (2019). Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy. BMC Cancer. 19(1). 857–857. 86 indexed citations

19.

Lalani, Aly‐Khan A., Wanling Xie, Dylan J. Martini, et al.. (2018). Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 6(1). 5–5. 197 indexed citations

20.

Lalani, Aly‐Khan A., Wanling Xie, Dylan J. Martini, et al.. (2017). Change in neutrophil-to-lymphocyte ratio (NLR) in response to immunotherapy for metastatic renal cell carcinoma (mRCC). Annals of Oncology. 28. v314–v315.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact